# Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava

> **NCT05081882** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 20 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Kava
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05081882
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05081882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05081882, "Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05081882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*